CLINICAL CHARACTERISTICS AND OUTCOMES OF EARLY-STAGE DIFFUSE LARGE B CELL LYMPHOMA OF FEMALE GENITAL TRACK: A RETROSPECTIVE STUDY OF THE HELLENIC COOPERATIVE LYMPHOMA GROUP

EHA Library, Evgenia Verrou, 421739

THE DEFINITION AND USE OF BULK DISEASE IN PHASE 3 LYMPHOMA TRIALS: A COMPREHENSIVE LITERATURE REVIEW

EHA Library, Luke Wang, 421740

INCIDENCE AND SURVIVAL OF HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS OVER TWO DECADES: A DANISH POPULATION-BASED STUDY

EHA Library, Mads Okkels Birk Lorenzen, 421741

DISTINCT CHARACTERISTICS AND SOCIAL DETERMINANTS IN ADULT T-CELL LEUKEMIA/LYMPHOMA PATIENTS FROM TORONTO

EHA Library, Tomohiro Aoki, 421742

IMPACT OF RESPONSE TO STEROID ADMINISTRATION BEFORE CHEMOIMMUNOTHERAPY ON PROGNOSIS IN NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Kikuaki Yoshida, 421743

PRIMARY GASTROINTESTINAL LYMPHOMA – EPIDEMIOLOGY, TREATMENT, AND OUTCOMES IN A 25-YEAR SINGLE CENTER EXPERIENCE

EHA Library, Karla Misura Jakobac, 421744

R2-GDP WITH LENALIDOMIDE MAINTENANCE FOR TRANSPLANT-INELIGIBLE RELAPSE REFRACTORY DLBCL UNDER CLINICAL TRIAL AND REAL-WORLD SETTINGS

EHA Library, Lawrence Ng, 421745

IMPACT OF EXTRAMEDIASTINAL INVOLVEMENT ON SURVIVAL METRICS IN PMBCL PATIENTS: INSIGHTS FROM A UNIFORM R-DA-EPOCH PROTOCOL

EHA Library, Runiza Abdurashidova, 421746

OUTCOMES OF PEDIATRIC AND YOUNG ADULTS’ PATIENTS TREATED FOR LYMPHOBLASTIC LYMPHOMA BY EORTC 58859 PROTOCOL– A SINGLE CENTER EXPERIENCE.

EHA Library, Imen Ben Amor, 421747

TREATMENT OUTCOMES OF R-CHOP WITHOUT RADIOTHERAPY FOR UNTREATED LIMITED-STAGE DIFFUSE LARGE B-CELL LYMPHOMA: SUPPLEMENTARY ANALYSIS OF JCOG0601

EHA Library, Yo Saito, 421748

MOSUNETUZUMAB WITH POLATUZUMAB VEDOTIN: SUBGROUP ANALYSES IN PATIENTS (PTS) WITH PRIMARY REFRACTORY OR EARLY RELAPSED LARGE B-CELL LYMPHOMA (LBCL)

EHA Library, Manali Kamdar, 421749

INCIDENCE RATES AND TRENDS OF LARGE B-CELL LYMPHOMA IN SPAIN (2002-2016): A POPULATION-BASED STUDY

EHA Library, rafael marcos-gragera, 421751

PRIMARY CUTANEOUS DIFFUSE LARGE B-CELL LYMPHOMA: OWN EXPERIENCE OF DIAGNOSIS AND EFFECTIVE TREATMENT PROTOCOLS.

EHA Library, Liliya Gorenkova, 421752

A RETROSPECTIVE STUDY ON THE USE OF R-COMP IN TREATMENT OF DLBCL PATIENTS: WHEN A SAMPLE IS NOT BIAS SELECTED

EHA Library, Luigi Rigacci, 421753

REVIEW OF NATIONWIDE INPATIENT REGISTRY TO ANALYZE THE RISK AND OUTCOMES OF TUMOR LYSIS SYNDROME OF PATIENT ADMITTED FOR AGGRESSIVE B CELL LYMPHOMAS.

EHA Library, Muhammad Farooq, 421754

A DIAGNOSTIC PREDICTIVE MODEL FOR DISTINGUISHING INTRAVASCULAR LARGE B-CELL LYMPHOMA IN PATIENTS WITH FEVER OF UNKNOWN ORIGIN

EHA Library, Chao Chen, 421755

TAFASITAMAB FOR THE TREATMENT OF RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) IN THE US REAL-WORLD SETTING

EHA Library, Kimberly Saverno, 421756

EFFICACY AND SAFETY OF POLA-R-CHP THERAPY IN ELDERLY PATIENTS OVER 80 YEARS WITH NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA: A REAL-WORLD OBSERVATIONAL STUDY

EHA Library, Masaaki Hotta, 421757

COMPARATIVE EFFECTIVENESS OF NHL-BFM-90 AND R-CHOEP CHEMOTHERAPY PROTOCOLS IN HIV-INFECTED PATIENTS WITH BURKITT'S LYMPHOMA

EHA Library, Chingiz Mabudzada, 421758

SELINEXOR IN COMBINATION WITH R-EPOCH FOR PATIENTS WITH PREVIOUSLY UNTREATED HIV-ASSOCIATED DIFFUSE LARGE B CELL LYMPHOMA(DLBCL)

EHA Library, Chaoyu Wang, 421759

THE IMPACT OF INTENSIVE CHEMOTHERAPY AND RADIOTHERAPY ON PLASMABLASTIC LYMPHOMA OUTCOMES

EHA Library, Philip Haddad, 421760

ZANBRUTINIB PLUS RITUXIMAB FOR THE TREATMENT OF OLDER UNFIT PATIENTS WITH PREVIOUSLY UNTREATED DIFFUSE LARDGE B CELL LYMPHOMA

EHA Library, Hui Liu, 421761

CONSTRUCTION OF A PREDICTIVE MODEL FOR SURVIVAL RISK IN PATIENTS WITH PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA BASED ON MACHINE LEARNING

EHA Library, Liping Su, 421762

T-CELL/HISTOCYTE B-CELL RICH LYMPHOMA (THRBCL) TREATMENT WITH R-CHOEP PLUS VENETOCLAX (SURVIVAL ADVANTAGE)

EHA Library, Maher Salamoon, 421763

SELINEXOR COMBINED WITH TISLELIZUMAB IN PATIENTS WITH RELAPSED OR REFRACTORY EXTRANODAL NK/T-CELL LYMPHOMA (R/R ENKTL): RESULTS OF DOSE ESCALATION OF COHORT C FROM PHASE I/II STUDY TOUCH

EHA Library, Rong Tao, 421764

ZANUBRUTINIB IN DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS WITH POOR PROGNOSTIC GENETIC MUTATIONS: A PROPENSITY SCORE MATCHED ANALYSIS

EHA Library, Wenrong Huang, 421765

EFFICIENCY AND SAFETY OF ZANUBRUTINIB COMBINED WITH R-CHOP REGIMEN IN THE TREATMENT OF NEWLY DIAGNOSED PATIENTS WITH DOUBLE EXPRESSOR DIFFUSE LARGE B-CELL LYMPHOMA: A SINGLE-CENTER RETROSPECTIVE STUDY

EHA Library, Xiaojing Xing, 421766

THE EFFICACY OF HIGH DOSE METHOTREXATE IN THE PROPHYLAXIS OF CENTRAL NERVOUS SYSTEM RELAPSE IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA AT HIGH RISK : A RETROSPECTIVE BICENTRIC STUDY IN REAL LIFE.

EHA Library, CAILLET Adrien, 421767

CENTRAL NERVOUS SYSTEM INVOLVEMENT IN EXTRANODAL NATURAL KILLER/T-CELL LYMPHOMA: A RETROSPECTIVE STUDY OF A CONSECUTIVE 13-YEAR CASE SERIES

EHA Library, Liang Wang, 421768

REAL WORLD DATA OF ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY FOR ADULT PATIENTS WITH REFRACTORY/RELAPSED HIGH GRADE B CELL LYMPHOMA AND MANTLE CELL LYMPHOMA IN ONE CENTRE IN SOUTHERN GREECE.

EHA Library, Stavros Papadakis, 421769

MITOXANTRONE HYDROCHLORIDE LIPOSOME, GEMCITABINE, VINORELBINE WITH OR WITHOUT RITUXIMAB (GVM±R) IN PATIENTS WITH RELAPSED OR REFRACTORY AGGRESSIVE NON-HODGKIN'S LYMPHOMA

EHA Library, Wei Liu, 421770

EXPLORING FRONTIERS: A DECADE OF EARLY PHASE CLINICAL TRIALS AT A LEADING TERTIARY CENTER.

EHA Library, SERGIO RAMOS, 421771

REAL-LIFE STUDY OF POLATUZUMAB VEDOTIN, BENDAMUSTINE AND RITUXIMAB FOR STAGE IV HIGH-INTERMEDIATE/HIGH RISK DLBCL OR INDOLENT TRANSFORMED IN RELAPSED/REFRACTORY SITUATION

EHA Library, André Pardal, 421772

THE LONG-TERM IMPACT OF RITUXIMAB-BASED CHEMOIMMUNOTHERAPY IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA, REAL WORLD OUTCOMES USING NATIONAL HEALTH INSURANCE DATABASE OF SOUTH KOREA.

EHA Library, Hyun Jung Lee, 421774

COMBINATION OF MITOXANTRONE HYDROCHLORIDE LIPOSOME WITH CYCLOPHOSPHAMIDE, VINCRISTINE, ETOPOSIDE AND PREDNISONE (CMOEP) IN TREATMENT-NAIVE PATIENTS WITH PERIPHERAL T-CELL LYMPHOMA: A PHASE ONE STUDY

EHA Library, Jingwei Yu, 421775

SAFETY AND EFFICACY OF AUTOLOGOUS HSCT IN ELEVEN PATIENTS WITH AIDS-RELATED NON-HODGKIN LYMPHOMA

EHA Library, Jun Liu, 421776

EFFICACY AND SAFETY ANALYSIS OF COMBINATION THERAPY BASED ON MITOXANTRONE HYDROCHLORIDE LIPOSOME INJECTION IN RELAPSED/REFRACTORY NK/T-CELL LYMPHOMA

EHA Library, Liang Wang, 421777

« LONG-TERM RESULTS OF TREATMENT OF PATIENTS WITH THE PRIMARY DIFFUSE LARGE B-CELL LYMPHOMA OF THE CENTRAL NERVOUS SYSTEM (PCNSL) ACCORDING TO THE “CNS-2015” STUDY»

EHA Library, Daria Koroleva, 421778

ACUTE KIDNEY INJURY WITHIN 30 DAYS FOLLOWING CD19-DIRECTED CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY IS ASSOCIATED WITH INFERIOR SURVIVAL IN PATIENTS WITH RELAPSED/REFRACTORY AGGRESSIVE B-CELL LYMPHOMA

EHA Library, John Sharp, 421779

PHASE 2 SEARCH STUDY：SELINEXOR (ATG-010) MONOTHERAPY IN HEAVILY PRETREATED CHINESE PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Song Yuqin, 421780

CONFIRMATION OF THE EXCELLENT OUTCOMES WITH BRENTUXIMAB-NIVOLUMAB FOR RELAPSED REFRACTORY PRIMARY MEDIASTINAL B-CELL LYMPHOMA IN THE REAL-WORLD SETTING

EHA Library, Lucy Pickard, 421781

REAL-WORLD EXPERIENCE OF GLOFITAMAB THERAPY IN PATIENTS WITH B-CELL NON-HODGKIN LYMPHOMA

EHA Library, Liudmila Fedorova, 421782

CLINICAL OUTCOME AND PROGNOSTIC FACTORS OF ELDERLY DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS: A RETROSPECTIVE SINGLE CENTRE STUDY

EHA Library, Yu Peng, 421783

ASSOCIATION OF PAKT1 AND AIF BIOMARKERS WITH THE PROGNOSIS OF DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Elena Vaneeva, 421784

ACALABRUTINIB IN COMBINATION WITH RITUXIMAB AND REDUCED DOSE CHOP (R-MINICHOP) IN OLDER ADULTS WITH UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA – ARCHED/GLA 2022-1, A GERMAN LYMPHOMA ALLIANCE STUDY

EHA Library, Igor Age Kos, 421785

A RETROSPECTIVE STUDY ON THE EFFICACY AND SAFETY OF CHIDAMIDE AS MAINTENANCE THERAPY OF PERIPHERAL T-CELL LYMPHOMA (PTCL)(NCT05967949)

EHA Library, Haorui Shen, 421786

SEQUENTIAL CD19/22 CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY FOLLOWING AUTOLOGOUS STEM CELL TRANSPLANTATION FOR RELAPSED/REFRACTORY LARGE B-CELL NON-HODGKIN'S LYMPHOMA

EHA Library, Caixia Li, 421787

PROGNOSTIC VALUE OF CACHEXIA INDEX DETERMINED BY BIOELECTRICAL IMPEDANCE ANALYSIS IN DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS UNDERGOING R-CHOP CHEMOTHERAPY

EHA Library, Young Hoon Park, 421788

TWENTY-YEAR SINGLE-CENTER EXPERIENCE TREATING PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL): ADMINISTER BEST THERAPY FIRST

EHA Library, Sotirios Bristogiannis, 421789

PATTERNS OF PRIMARY LARGE B CELL TESTICULAR LYMPHOMA RELAPSES IN THE RITUXIMAB ERA

EHA Library, Suheil Albert Atallah-Yunes, 421790

THE DISPARITY OF CIRCULATING IMMUNE CELL SUBSETS AND INFLAMMATORY STATUS BETWEEN HIV-POSITIVE AND HIV-NEGATIVE PATIENTS WITH LYMPHOMA

EHA Library, Qing Xiao, 421791

EFFICACY AND SAFETY OF MECAPEGFILGRASTIM IN PREVENTING CHEMOTHERAPY-INDUCED NEUTROPENIA IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Ting Niu, 421792

CYCLOPHOSPHAMIDE, MITOXANTRONE HYDROCHLORIDE LIPOSOME, VINCRISTINE, AND PREDNISONE REGIME WITH OR WITHOUT RITUXIMAB (CMOP±R) SHOWS HIGH EFFICACY AS A FIRST-LINE TREATMENT FOR NON-HODGKIN'S LYMPHOMA

EHA Library, Tao You, 421793

ZANUBRUTINIB COMBINED WITH R-CHOP REGIMEN IN THE TREATMENT OF UNTREATED NON-GERMINAL CENTER B-CELL SUBTYPE DIFFUSE LARGE B-CELL LYMPHOMA WITH MULTIPLE EXTRANODAL INVOLVEMENT.

EHA Library, Caixia Li, 421794

BASELINE MONOCYTE-TO-PLATELETS RATIO (MPR) IS ASSOCIATED WITH INFERIOR PROGRESSION-FREE SURVIVAL IN PATIENTS WITH MANTLE CELL LYMPHOMA: A MULTI-CENTER REAL-LIFE SURVEY

EHA Library, Andrea Duminuco, 421795

PRELIMINARY INVESTIGATION OF THE EFFICACY AND SAFETY OF ZANUBRUTINIB IN COMBINATION WITH R-CHEMO AS FIRST-LINE THERAPY IN PATIENTS WITH NEWLY DIAGNOSED MANTLE CELL LYMPHOMA

EHA Library, Haiwen Huang, 421796

XPO-1 INHIBITOR SELINEXOR IN COMBINATION WITH RCHOP IS AN EFFECTIVE CHEMOTHERAPY REGIMEN FOR PATIENTS WITH DOUBLE/TRIPLE-HIT LARGE B-CELL LYMPHOMA.

EHA Library, Haiyan Yang, 421797

INCIDENCE, PREVALENCE AND TRENDS OF B CELL LYMPHOMA IN URBAN CHINA: A NATIONWIDE POPULATION-BASED STUDY

EHA Library, Yinchu Cheng, 421799

DIFFERENT SUBTYPE OF DLBCL PATIENTS TREATED WITH R-CHOP(LIKE) PLUS ORELABRUTINIB REGIMEN: A REAL-WORLD STUDY

EHA Library, Wei Xu, 421800

LINPERLISIB IN COMBINATION WITH CHOP FOR NEWLY-DIAGNOSED PERIPHERAL T-CELL LYMPHOMA: PRELIMINARY RESULTS FROM THE PHASE 1B/2 LINCH STUDY

EHA Library, Qingqing Cai, 421801

ORELABRUTINIB, RITUXIMAB AND HIGH-DOSE METHOTREXATE (HD-MTX) IN NEWLY DIAGNOSED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL): A RETROSPECTIVE ANALYSIS ON EFFICACY AND SAFETY

EHA Library, Shujuan Wen, 421802

CHIDAMIDE IN COMBINATION WITH R-CHOP-LIKE CHEMOTHERAPY FOR PREVIOUSLY UNTREATED GERMINAL CENTER B-CELL-LIKE MYC/BCL2 DOUBLE-EXPRESSER DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Wenyu Li, 421803

CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY IN AGGRESSIVE B-CELL LYMPHOMA OF CENTRAL NERVOUS SYSTEM (CNS): RESULTS FROM A RETROSPECTIVE ANALYSIS

EHA Library, Georg-Nikolaus Franke, 421804

INCORPORATING RADIATION WITH CAR T-CELL THERAPY  DEMONSTRATED A HIGH RATE OF REMISSION IN PATIENTS WITH B CELL LYMPHOMA INVOLVING THE CNS

EHA Library, Hui Shi, 421805

NUTRITIONAL STATUS AND INFLUENCING FACTORS ANALYSIS OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES DURING TRANSPLANT COMBINED WITH CAR-T CELL IMMUNOTHERAPY

EHA Library, yabin wang, 421806

A PHASE 1/2 TRIAL INVESTIGATING SAFETY, TOLERABILITY, AND PRELIMINARY ANTITUMOR ACTIVITY OF IPH6501, A FIRST-IN-CLASS NK CELL ENGAGER, IN PATIENTS WITH R/R CD20-EXPRESSING NHL

EHA Library, Lorenzo Falchi, 421807

TRIAL IN PROGRESS: PHASE 1 STUDY OF ARV-393, A PROTAC BCL6 DEGRADER, IN ADVANCED NON-HODGKIN LYMPHOMA

EHA Library, Paolo F Caimi, 421809

R-CHOP+X REGIMEN ACHIEVES HIGH RESPONSE RATE AND LONG-TERM SURVIVAL BENEFIT IN THE TREATMENT OF BN2 AND MCD SUBTYPES OF NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Tingting Chen, 421811

REAL-WORLD 7-YEAR SINGLE-CENTER EXPERIENCE IN THE MANAGEMENT OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA

EHA Library, Vojin Vukovic, 421813

HBV ANTIGEN HBX PROMOTES DIFFUSE LARGE B-CELL LYMPHOMA CHEMORESISTANCE THROUGH THE NF-KB/XIAP PATHWAY

EHA Library, Zhumei Zhan, 421814

EFFICACY AND SAFETY OF POLATUZUMAB VEDOTIN, RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN AND PREDNISONE IN PREVIOUSLY UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS: A REAL-WORLD STUDY IN CHINA

EHA Library, Yuhong Ren, 421815

EFFICACY EVALUATION AND SAFETY ANALYSIS OF ZANUBRUTINIB COMBIDED WITH RITUXIMAB AND LENALIDOMIDE FOR REFRACTORY RECURRENT AND NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA IN THE ELDELY

EHA Library, Chunxia Zhang, 421816

R-CHOP VERSUS DOSE-ADJUSTED-EPOCH-R AS A FIRST LINE THERAPY IN DOUBLE EXPRESSOR DLBCL A SINGLE CENTER EXPERIENCE

EHA Library, Sofija Pantelic, 421817

TOXICITY PROFILE OF THE LMB01 PROTOCOL IN THE TREATMENT OF PATIENTS WITH BURKITT LYMPHOMA

EHA Library, rihab ben sghaier, 421818

PREVALENCE AND TOXICITY MANAGEMENT OF CD20XCD3 BISPECIFIC  ANTIBODIES FOR B-CELL LYMPHOMAS IN THE STANDARD OF CARE SETTING

EHA Library, Ning Dong, 421819

PROGNOSTIC SIGNIFICANCE OF Β2-MICROGLOBULIN IN PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA

EHA Library, Rukesh Yadav, 421820

COMPARISON OF [18F]FDG OR [18F]FET PET WITH MRI FOR RESPONSE EVALUATION IN PRIMARY CNS LYMPHOMA PATIENTS TREATED WITH HIGH-DOSE METHOTREXATE-BASED REGIMEN

EHA Library, Minyoung Oh, 421821

UPFRONT AUTOLOGOUS STEM CELL TRANSPLANTATION CAN CURE A HIGH PERCENTAGE OF HIGH-INTERMEDIATE/HIGH-RISK AGGRESSIVE LYMPHOMA:  RESULTS OF A MONOCENTRIC RETROSPECTIVE SERIES

EHA Library, Alessandra Tucci, 421822

EARLY PROGRESSION AS A PREDICTOR OF SURVIVAL IN HODGKIN AND B-CELL NON HODGKIN LYMPHOMA, IN THE REAL WORLD: THE UKRAINIAN LYMPHOMA REGISTRY-BASED STUDY.

EHA Library, Nazar Shokun, 421823

TREATMENT WITH BISPECIFIC ANTIBODIES IN PATIENT WITH RELAPSED / REFRACTORY NON-HODGKIN LYMPHOMA (NHL)

EHA Library, Barbara Dreta, 421824

INFUSION-RELATED REACTIONS IN PATIENTS WITH CHRONIC LYMPHOPROLIFERATIVE DISORDERS TREATED WITH TWO RITUXIMAB BIOSIMILARS: SINGLE CENTER EXPERIENCE

EHA Library, Vojin Vukovic, 421825

CELL-FREE DNA LEVELS IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Tatyana Rybolovleva, 421826

REAL LIFE EXPERIENCE FROM A SINGLE UNIT IN GREECE: EXCELLENT OUTCOME FOR MANTLE CELL LYMPHOMA (MCL) COMPARED TO DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) WITH CAR T CELL THERAPY

EHA Library, Eleni Siavou, 421827

RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: IS SECOND-LINE IMMUNOCHEMOTHERAPY STILL A CHOICE?

EHA Library, Rita Azevedo Costa Sousa, 421828

AGGRESSIVE T-CELL LARGE GRANULAR LYMPHOCYTIC LEUKEMIA WITH AN UNUSUAL DOUBLE-NEGATIVE CD4- CD8- TCRΑΒ+ IMMUNOPHENOTYPE

EHA Library, Angeliki Kotsiafti, 421829

THERAPEUTIC RESULTS OF ADULT’S LYMPHOBLASTIC LYMPHOMA

EHA Library, Hana BEN HAMMAMIA, 421830

OUTCOMES IN BURKITT POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER AFTER SOLID ORGAN TRANSPLANTATION: A SINGLE CENTER EXPERIENCE

EHA Library, Daniel Gil-Alós, 421831

EFFICACY AND SAFETY OF POLATUZUMAB VEDOTIN IN DIFFUSE LARGE B-CELL LYMPHOMA：A SINGLE-CENTER REAL-WORLD ANALYSIS FROM CHINA

EHA Library, Haiyan Yang, 421832

EVALUATION OF OVERALL SURVIVAL AND TOXICITY IN PATIENTS WITH BURKITT LYMPHOMATREATED WITH BURKIMAB 13 PROTOCOL

EHA Library, Ana Romina Montivero, 421833

CEREBROSPINAL FLUID INVESTIGATION IN DIFFUSE LARGE B-CELL LYMPHOMAS AT DIAGNOSIS.

EHA Library, Luigi Rigacci, 421834

A STUDY OF THE RELATIONSHIP BETWEEN CIRCULATING CYTOKINES (INTERLEUKIN-2 RECEPTOR AND TUMOR NECROSIS FACTOR RECEPTOR 2) AND RISK OF B-CELL NON-HODGKIN LYMPHOMA

EHA Library, Sara El-sayed, 421835

CNS PROPHYLAXIS IN PATIENTS WITH DLBCL: A REAL WORLD EXPERIENCE ON BEHALF OF THE LYMPHOMA SUBCOMMITTEE OF THE ARGENTINE SOCIETY OF HEMATOLOGY

EHA Library, Fernando Warley, 421836

DOSE ADJUSTED R-EPOCH IN PRIMARY MEDIASTINAL B-CELL LYMPHOMA DURING PREGNANCY

EHA Library, Yana MANGASAROVA, 421837

EXAMINING THE TREATMENT PATTERNS AND CLINICAL OUTCOMES OF PATIENTS WITH PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA:  AN INTERNATIONAL MULTICENTER LONG TERM CLINICAL STUDY

EHA Library, Maria Jana Kingsley-Godwin, 421838

EFFICACY OF DA-EPOCH IN PERIPHERAL T-CELL LYMPHOMAS

EHA Library, Rishabh Jain, 421839

COMPARATIVE ANALYSIS OF BLOOD PARAMETER KINETICS IN PATIENTS TREATED WITH TYPE I AND TYPE II ANTI-CD20 ANTIBODIES

EHA Library, Elina Beleva, 421840

OVERALL SURVIVAL (OS) AND REAL-WORLD OVERALL RESPONSE RATE (ORR) OF DIFFUSE LARGE B-CELL LYMPHOMA WITH POLATUZUMAB VEDOTIN-BASED THERAPY, A MULTICENTRIC STUDY IN MEXICO

EHA Library, Silvia Margarita Rodriguez Mejorada, 421841

GOLSEEK-1: A PHASE 3, DOUBLE-BLIND, RANDOMIZED STUDY COMPARING THE EFFICACY AND SAFETY OF GOLCADOMIDE PLUS R-CHOP VS R-CHOP IN PATIENTS WITH PREVIOUSLY UNTREATED, HIGH-RISK, LARGE B-CELL LYMPHOMA

EHA Library, Theodoros Vassilakopoulos, 421842

POLA-R-CHP FOR DIFFUSE LARGE B CELL LYMPHOMA WITH HIGH EXPRESSION OF P53 PROTEIN

EHA Library, Xia Zhao, 421843

SINGLE CENTER EXPERIENCE OF DA-EPOCH-R AS FRONTLINE TREATMENT FOR AGGRESSIVE DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)

EHA Library, Eugenia Montanari, 421844